MS100015-0019: Open-label, Phase I, Dose Escalation Trial, investigating Methionine Aminopeptidase 2 Inhibitor M8891 in Subjects with Advanced Solid Tumors

August 25, 2017
https://clinicaltrials.gov/ct2/show/NCT03138538
Solid Tumors
Principal Investigator: Ding Wang, MD
Advanced Solid Tumors
Accepting Participants
(313)916-1784